These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 473592)

  • 21. Naturally occurring temperature-sensitive influenza A viruses of the H1N1 and H3N2 subtypes.
    Oxford JS; Corcoran T; Schild GC
    J Gen Virol; 1980 Jun; 48(Pt 2):383-9. PubMed ID: 7400776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
    Ghendon YZ; Polezhaev FI; Lisovskaya KV; Medvedeva TE; Alexandrova GI; Klimov AI
    Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a cold-recombinant influenza virus vaccine in ferrets.
    Maassab HF; Kendal AP; Abrams GD; Monto AS
    J Infect Dis; 1982 Dec; 146(6):780-90. PubMed ID: 7142749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.
    Mortiz AJ; Kunz C; Hofman H; Liehl E; Reeve P; Maassab HF
    J Infect Dis; 1980 Dec; 142(6):857-60. PubMed ID: 7462697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temperature-sensitive mutants of influenza A virus: transfer of the two temperature-sensitive lesions in the Udorn/72-ts-1A2 virus to the A2Hong Kong/123/77 (H1N1) wild-type virus.
    Murphy BR; Hosier NT; Chanock RM
    Infect Immun; 1980 Jun; 28(3):792-8. PubMed ID: 7399695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genes associated with trans-dominance of the influenza A cold-adapted live virus vaccine.
    Whitaker-Dowling P; Zvolenski R; Youngner JS
    Virology; 1991 Jan; 180(1):81-7. PubMed ID: 1984670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
    Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM
    Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic recombination between natural isolates of influenza virus serotypes H1N1 and H3N2].
    Kozlov IuV; Shilov AA; Chaĭka OV; Kurmanova AG; Zhdanov VM
    Vopr Virusol; 1987; 32(6):660-6. PubMed ID: 3445583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.
    Beare AS; Kendal AP; Cox NJ; Scholtissek C
    Infect Immun; 1980 Jun; 28(3):753-61. PubMed ID: 7399693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.
    Steinhoff MC; Halsey NA; Fries LF; Wilson MH; King J; Burns BA; Samorodin RK; Perkis V; Murphy BR; Clements ML
    J Infect Dis; 1991 May; 163(5):1023-8. PubMed ID: 2019751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. I. biologic, genetic, and biochemical characterization.
    Reeve P; Almond JW; Felsenreich V; Pibermann M; Maassab HF
    J Infect Dis; 1980 Dec; 142(6):850-6. PubMed ID: 7462696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants.
    Watanabe T; Bartrand TA; Omura T; Haas CN
    Risk Anal; 2012 Mar; 32(3):555-65. PubMed ID: 21977924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.